2020 annual financial data
INmune Bio 2020 Operating cash flow margin
Direct answer
Operating cash flow margin was -81,931.53%.
Operating income was -12,227,676 USD and net income was -12,099,159 USD.
Operating cash flow was -8,943,646 USD.
Get free INmune Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 10,916 USD
- Operating income
- -12,227,676 USD
- Net income
- -12,099,159 USD
- Operating cash flow
- -8,943,646 USD